| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8827039 | Transplantation Proceedings | 2018 | 10 Pages |
Abstract
The use of aLDLT in patients with HCC within and beyond Milan but within the BCLC expanded criteria offers acceptable survival and recurrence rates. Therefore, we believe that its use in this scenario is justified.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
M.C. Pavel, S. Sanchez Cabus, G. Crespo, J. Ferrer, C. Fondevila, J. Fuster, J.C. Garcia-Valdecasas,